ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
US Tech 100
20,030.00
-1.27%
Dow Jones
41,938.45
-1.63%
Brent Oil
80.375
-0.30%
Bitcoin
91,526.05
-3.14%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Revelation Biosciences Inc (REVB)

  7. Revelation Biosciences Inc (REVB) News

REVB

Revelation Biosciences (REVB)

Revelation Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REVB
DateTimeSourceHeadlineSymbolCompany
01/06/20256:00AMBusiness WireNasdaq Grants Revelation Biosciences Inc. Continued ListingNASDAQ:REVBRevelation Biosciences Inc
12/03/20248:38AMBusiness WireRevelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross ProceedsNASDAQ:REVBRevelation Biosciences Inc
12/02/20246:00AMBusiness WireRevelation Biosciences Inc. Announces FDA Acceptance of Gemini INDNASDAQ:REVBRevelation Biosciences Inc
11/12/20246:00AMBusiness WireRevelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug SupplyNASDAQ:REVBRevelation Biosciences Inc
11/08/20244:15PMBusiness WireRevelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024NASDAQ:REVBRevelation Biosciences Inc
09/24/20246:00AMBusiness WireRevelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10NASDAQ:REVBRevelation Biosciences Inc
09/03/20245:09PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:REVBRevelation Biosciences Inc
08/26/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:REVBRevelation Biosciences Inc
08/21/20245:30PMBusiness WireRevelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross ProceedsNASDAQ:REVBRevelation Biosciences Inc
08/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:REVBRevelation Biosciences Inc
08/09/20244:15PMBusiness WireRevelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024NASDAQ:REVBRevelation Biosciences Inc
08/02/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:REVBRevelation Biosciences Inc
07/29/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:REVBRevelation Biosciences Inc
07/19/20244:02PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:REVBRevelation Biosciences Inc
06/24/20249:00AMBusiness WireRevelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker ActivityNASDAQ:REVBRevelation Biosciences Inc
06/13/20249:21AMBusiness WireRevelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of GeminiNASDAQ:REVBRevelation Biosciences Inc
05/10/20244:52PMBusiness WireRevelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024NASDAQ:REVBRevelation Biosciences Inc
03/22/20244:15PMBusiness WireRevelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023NASDAQ:REVBRevelation Biosciences Inc
03/13/20249:00AMBusiness WireRevelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)NASDAQ:REVBRevelation Biosciences Inc
03/12/20249:00AMBusiness WireRevelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth ConferenceNASDAQ:REVBRevelation Biosciences Inc
03/04/20249:00AMBusiness WireRevelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of GeminiNASDAQ:REVBRevelation Biosciences Inc
02/13/20248:12PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:REVBRevelation Biosciences Inc
02/13/20249:00AMBusiness WireRevelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)NASDAQ:REVBRevelation Biosciences Inc
02/12/202410:19AMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:REVBRevelation Biosciences Inc
02/08/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:REVBRevelation Biosciences Inc
02/05/20244:41PMBusiness WireRevelation Biosciences Inc. Announces Closing of $6.2 Million Public OfferingNASDAQ:REVBRevelation Biosciences Inc
02/02/20244:06PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:REVBRevelation Biosciences Inc
02/01/20246:00AMBusiness WireRevelation Biosciences Inc. Announces Pricing of $6.2 Million Public OfferingNASDAQ:REVBRevelation Biosciences Inc
02/01/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:REVBRevelation Biosciences Inc
01/30/20245:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:REVBRevelation Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:REVB

Your Recent History

USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NBRI
North Bay Resources (PK)
NASDAQ
COOP
Mr Cooper
USOTC
SPZI
Spooz (PK)
NASDAQ
TSLA
Tesla
USOTC
MONI
Moon Equity (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
RDAR
Raadr (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
ELTP
Elite Pharmaceuticals (QB)
COIN
XRPUSD
Ripple
USOTC
AABB
Asia Broadband (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads